Journal
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
Volume 14, Issue 2, Pages -Publisher
WILEY
DOI: 10.1002/wnan.1763
Keywords
inflammation-modulating biomaterials; lung injury; nanoparticles; pneumonia; stimuli-responsive
Funding
- Natural Science Foundation of Zhejiang Province [LD21E030001]
- National Natural Science Foundation of China [51873188]
- Fundamental Research Funds for the Central Universities of China [2020XZZX004-01]
Ask authors/readers for more resources
Pneumonia is a common yet serious infectious disease, where pathogens interact with the lungs to cause inflammation response. While pharmacotherapies are effective, developing inflammation modulation nanoparticles show promise in alleviating pneumonia and acute lung injury.
Pneumonia is a common but serious infectious disease, and is the sixth leading cause for death. The foreign pathogens such as viruses, fungi, and bacteria establish an inflammation response after interaction with lung, leading to the filling of bronchioles and alveoli with fluids. Although the pharmacotherapies have shown their great effectiveness to combat pathogens, advanced methods are under developing to treat complicated cases such as virus-infection and lung inflammation or acute lung injury (ALI). The inflammation modulation nanoparticles (NPs) can effectively suppress immune cells and inhibit inflammatory molecules in the lung site, and thereby alleviate pneumonia and ALI. In this review, the pathological inflammatory microenvironments in pneumonia, which are instructive for the design of biomaterials therapy, are summarized. The focus is then paid to the inflammation-modulating NPs that modulate the inflammatory cells, cytokines and chemokines, and microenvironments of pneumonia for better therapeutic effects. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available